Diabetes and Parenteral Nutrition

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review


Use of parenteral nutrition (PN) serves as an option for provision of macro- and micronutrients in patients with a nonfunctional gastrointestinal tract. Treatment with PN contributes to clinical improvement in appropriate patients; however, metabolic effects and complications may develop. Common complications include line infections, liver disease as both cholestasis and hepatosteatosis, hypertriglyceridemia, and hyperglycemia. The risk for each of these complications is increased in patients with either type 1 or type 2 diabetes mellitus. Risk reduction and treatment of complications may be attained through adjustment of the PN formula. Reduction of dextrose content, use of a fish oil-based lipid formulation, appropriate micronutrient supplementation, and coordinated administration of insulin can address the risks of PN administration, especially among patients with diabetes mellitus.

Original languageEnglish
Title of host publicationContemporary Endocrinology
PublisherHumana Press Inc.
Number of pages14
StatePublished - 2023

Publication series

NameContemporary Endocrinology
VolumePart F2156
ISSN (Print)2523-3785
ISSN (Electronic)2523-3793


  • Fish oil
  • Hepatosteatosis
  • Hyperglycemia
  • Hypertriglyceridemia
  • Line infection
  • Parenteral nutrition


Dive into the research topics of 'Diabetes and Parenteral Nutrition'. Together they form a unique fingerprint.

Cite this